Роль гипергликемии в периоперационном периоде при проведении аортокоронарного шунтирования
Аннотация
В статье представлены патофизиологические особенности гипергликемии, ее негативное воздействие на сердечно-сосудистую систему, показаны пути достижения оптимального периоперационного гликемического контроля, а также обсуждены результаты исследований, направленных на определение оптимального уровня гликемии, необходимого для предотвращения послеоперационных осложнений и достижения оптимальных клинических результатов.
Об авторах
Р. Р. Ярбеков
ФГБУ «Научный центр сердечно-сосудистой хирургии им. А.Н. Бакулева»
Россия
Россия
Ярбеков Рустам Раимкулович – к.м.н., докторант
А. А. Назаров
ФГБУ «Научный центр сердечно-сосудистой хирургии им. А.Н. Бакулева»
Россия
Россия
Назаров Афанасий Анатольевич – аспирант
Список литературы
1. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery) / K.A. Eagle, R.A. Guyton, R. Davidoff [et al.] // Circulation. – 2004. – №110. – P. 340-437.
2. American association of clinical endocrinologists and american diabetes association consensus statement on inpatient glycemic control / S. Moghissi, M.T. Korytkowski, M. DiNardo [et al.] // Endocrine Practice. – 2009. – №15. – V4. – P. 353-369.
3. Are even impaired fasting blood glucose levels preoperatively associated with increased mortality after CABG surgery? / R.E. Anderson, K. Klerdal, T. Ivert [et al.] // European Heart Journal. – 2005. – №26. – V15. – P. 1513-1518.
4. Circulating adhesion molecules in humans: role of hyperglycemia and hyperinsulinemia / R. Marfella, K. Esposito, R. Gionata [et al.] // Circulation. – 2000. – №201. – P. 2247-2251.
5. Coronary artery bypass grafting in type II diabetic patients: a comparison between insulindependent and non-insulin-dependent patients at short- and mid-term follow-up / N. Luciani, G. Nasso, M. Gaudino [et al.] // Annals of Thoracic Surgery. – 2003. – №76. – V4. – P. 1149-1154.
6. Development and validation of a prediction model for strokes after coronary artery bypass grafting / C. Charlesworth, D.S. Likosky, C.A.S. Marrin [et al.] // Annals of Thoracic Surgery. – 2003. – №76. – V2. – Р. 436-443.
7. Effects of aggressive vs moderate glycemic control on clinical outcomes in diabetic coronary artery bypass graft patients / H.L. Lazar, M.M. McDonnell, S. Chipkin [et al.] // Annals of Surgery. – 2011. – №254. – V3. – P. 458-64.
8. Effect of diabetes and associated conditions on long-term survival after coronary artery bypass graft surgery / B.J. Leavitt, L. Sheppard, C. Maloney [et al.] // Circulation. – 2004. – №1101. – P. II41-II44.
9. Effect of risk-adjusted diabetes on mortality and morbidity after coronary artery bypass surgery / C. Kubal, A.K. Srinivasan, A.D. Grayson [et al.] // Annals of Thoracic Surgery. – 2005. – №79. – P. 1570-1576.
10. Endothelial dysfunction and type 2 diabetes. Part 2: altered endothelial function and the effects of treatments in type 2 diabetes mellitus / B. Guerci, P. Bohme, A. Kearney-Schwartz [et al.] // Diabetes and Metabolism. – 2001. – №27. – V41. – P. 436-47.
11. Expression of inducible nitric oxide synthase in conduits used in patients with diabetes mellitus undergoing coronary revascularization / H.L. Lazar, L. Joseph, C. San Mateo [et al.] // Journal of Cardiac Surgery. – 2010. – №25. – P. 120-126.
12. Glucose measurement: confounding issues in setting targets for inpatient management / K. Dungan, J. Chapman, S.S. Braithwaite [et al.] // Diabetes Care. – 2007. – №30. – V2. – P. 403- 409.
13. High levels of fatty acids delay the recovery of intracellular pH and cardiac efficiency in post¬ishemic hearts by inhibiting glucose oxidation / L.J.C. Docherty, J.C.T. Rendell, A.S. Clanachan [et al.] // Journal of the American College of Cardiology. – 2002. – №39. – V4. – Р. 718-725.
14. Krikorian A. Comparisons of different insulin infusion protocols: a review of recent literature / A. Krikorian, F. Ismail-Beigi, E.S. Moghissi // Current Opinion in Clinical Nutrition and Metabolic Care. – 2010. – №13. – V2. – P. 198- 204.
15. Lazar H.L. Glycemic Control during Coronary Artery Bypass Graft Surgery / H.L. Lazar // ISRN Cardiol. – 2012; 292490.
16. Hyperglycemia during cardiopulmonary bypass is an independent risk factor for mortality in patients undergoing cardiac surgery / T. Doenst, D. Wijeysundera, K. Karkouti [et al.] // Journal of Thoracic and Cardiovascular Surgery. – 2005. – №130. – V4. – P. 1144.el-l 144.e8.
17. Impact of admission serum glucose level on in-hospital outcomes following coronary artery bypass grafting surgery / S.A. Imran, T. P.P. Ransom, K.J. Buth [et al.] // Canadian Journal of Cardiology. – 2010. – №26. – V3. – P. 151—154.
18. Impact of hyperglycemia on perioperative mortality after coronary artery bypass graft surgery / J. Szekely, J. Levin, Y. Miao [et al.] // Journal of Thoracic and Cardiovascular Surgery. – 2011. – №142. – V2. – P. 430-437.
19. Insulin absorption: a major factor in apparent insulin resistance and the control of type 2 diabetes mellitus / S.J. Friedberg, Y.W. Lam, J.J. Blum [et al.] // Metabolism. – 2006. – №55. – V5. – P. 614-619.
20. Insulin attenuates the systemic inflammatory response in endotoxemic rats / M.G. Jeschke, D. Klein, U. Bolder [et al.] // Endocrinology. – 2004. – №145. – V9. – P. 4084-4093.
21. Insulin stimulates pyruvate dehydrogenase and protects human ventricular cardiomyocytes from simulated ischemia / V. Rao, F. Merante, R.D. Weisel [et al.] // Journal of Thoracic and Cardiovascular Surgery. – 1998. – №116. – V3. – P. 485-94.
22. Intensive insulin therapy protects the endothelium of critically ill patients / L. Langovche, I. Vanhorebeek, D. Vlaselaers [et al.] // The Journal of Clinical Investigation. – 2005. – №115. – P. 1177-1186.
23. London M. J. Association of fasttrack cardiac management and low-dose to moderate-dose glucocorticoid administration with perioperative hyperglycemia / M.J. London, M.J. Grunwald, A.L.W. Shroyer // Journal of Cardiothoracic and Vascular Anesthesia. – 2000. – №14. – V6. – P. 631-638.
24. Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemiareperfusion: the roles of PI3-kinase, Akt, and endothelial nitric oxide synthase phosphorylation / F. Gao, E. Gao, T.L. Yue [et al.] // Circulation. – 2002. – №105. – V12. – P. 1497-1502.
25. Outcomes and perioperative hyperglycemia in patients with or without diabetes mellitus undergoing coronary artery bypass grafting / C.A. Estrada, J.A. Young, L.W. Nifong [et al.] // Annals of Thoracic Surgery. – 2003. – №75. –V.5. – P.1392-1399.
26. Prevalence of the metabolic syndrome in patients with coronary heart disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm / P.M. Gorter, J.K. Olijhoek, Y. Van der Graaf [et al.] // Atherosclerosis. – 2004. – №173. – P. 363-369.
27. Reliability of point-of-care testing for glucose measurement in critically ill adults / J. Kanji, J. Buffie, B. Hutton [et al.] // Critical Care Medicine. – 2005. – №3. –V.3-12. – P. 2778-2785.
28. Safety and efficacy of continuous insulin infusion in noncritical care settings / L. Smiley, M. Rhee, L. Peng [et al.] // Journal of Hospital Medicine. – 2010. – №5. – V4. – P. 212-217.
29. Safety and effectiveness of a standardized 80-150 mg/dl iv insulin infusion protocol in the Medical Intensive Care Unit: >11, 000 hours of experience / E. Donihi, R. Rea, L. Haas [et al.] // Diabetes. – 2006. – №55. – Р. 459.
30. Sowers J.R. Diabetes mellitus and associated hypertension, vascular disease, and nephropathy / J.R. Sowers, M. Epstein // Hypertension. – 1995. – №26. – V6. – P. 869-879.
31. Superiority of moderate control of hyperglycemia to tight control in patients undergoing coronary artery bypass grafting / M. Bhamidipati, D. J. Lapar, G. J. Stukenborg [et al.] // Journal of Thoracic and Cardiovascular Surgery. – 2011. – №141. – V2. – P. 543–551.
32. The International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes / The International Expert Committee // Diabetes Care. – 2009. – №7. – P. 1327-1334.
33. The Society of Thoracic Surgeons Practice Guideline Series: blood glucose management during adult cardiac surgery / H.L. Lazar, M. McDonnell, S.R. Chipkin [et al.] // Annals of Thoracic Surgery. – 2009. – №87. – V2. – P. 663- 669.
34. Trauma metabolism and the heart. Uptake of substrates and effects of insulin early after cardiac operations / S. Svensson, R. Svedjeholm, R. Ekroth [et al.] // Journal of Thoracic and Cardiovascular Surgery. – 1990. – №99. – V6. – P. 1063-1073.
35. Use of intensive insulin therapy for the management of glycemic control in hospitalized patients: a clinical practice guideline from the American College of Physicians / L.L. Qaseem, R. Humphrey, V. Chou [et al.] // Annals of Internal Medicine. – 2011. – №154. – V4. – P. 260-267.
36. Value of postoperative blood glucose in predicting complications and length of stay after coronary artery bypass grafting / L.H. Fish, T.W. Weaver, A.L. Moore [et al.] // American Journal of Cardiology. – 2003; -№92. – V1. – P. 74-76.
37. Vlassara H. Recent progress in advanced glycation end products and diabetic complications / H. Vlassara // Diabetes. – 1997. – №46. – V2. – P. S19-S25.
Рецензия
Для цитирования:
Ярбеков Р.Р., Назаров А.А. Роль гипергликемии в периоперационном периоде при проведении аортокоронарного шунтирования. Якутский медицинский журнал. 2015;(1):56-60.
For citation:
Yarbekov R.R., Nazarov A.A. The Role of Hyperglycemia in the Perioperative Period in Carrying out Aortocoronary Shunting. Yakut Medical Journal. 2015;(1):56-60.
Просмотров:
3
Послать статью по эл. почте 